Biotech · Private company
UCB Biopharma S.P.R.L.
Track this companyFree. Adds UCB Biopharma S.P.R.L. to your Dealase workspace and tells you when its record changes.
Clinical trials240 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline20
- Certolizumab PegolPhase 3 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- e-DevicePhase 3 · Moderate and Severe Active Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- EtanerceptPhase 3 · PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- USL261Phase 3 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 2 · Ankylosing SpondylitisClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 2 · Chronic Plaque PsoriasisClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 2 · Psoriatic ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- BrivaracetamPhase 2 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Dapirolizumab pegol (DZP)Phase 2 · Systemic Lupus Erythematosus (SLE)ClinicalTrials.gov · fetched Nov 12, 2026
- LorazepamPhase 2 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- PadsevonilPhase 2 · Drug-resistant EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- RozanolixizumabPhase 2 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)ClinicalTrials.gov · fetched Nov 12, 2026
- UCB7665Phase 2 · Myasthenia GravisClinicalTrials.gov · fetched Nov 12, 2026
- BimekizumabPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- PadsevonilPhase 1 · Healthy Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- PadsevonilPhase 1 · Elderly Study ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- UCB0599Phase 1 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Kinesia-360™Parkinson´s DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Kinesia-ONE™Parkinson´s DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RotigotineParkinson´s DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials24
- A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic FunctionPHASE1 · TERMINATED · started Oct 28, 2019ClinicalTrials.gov NCT04136444 · fetched Nov 12, 2026
- A Study to Test the Safety and Tolerability of Single and Multiple Doses of Padsevonil in Adult and Elderly Study ParticipantsPHASE1 · COMPLETED · started Jul 9, 2019ClinicalTrials.gov NCT04013191 · fetched Nov 12, 2026
- A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD)PHASE1 · COMPLETED · started May 6, 2019ClinicalTrials.gov NCT04875962 · fetched Nov 12, 2026
- A Study to Evaluate the Antibody Response of Influenza Vaccination Following Concomitant Exposure to Bimekizumab in Healthy SubjectsPHASE1 · COMPLETED · started Apr 2, 2019ClinicalTrials.gov NCT03895385 · fetched Nov 12, 2026
- A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating PolyradiculoneuropathyPHASE2 · COMPLETED · started Mar 26, 2019ClinicalTrials.gov NCT03861481 · fetched Nov 12, 2026
- A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer ParticipantsPHASE1 · COMPLETED · started Oct 15, 2018ClinicalTrials.gov NCT03707717 · fetched Nov 12, 2026
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With EpilepsyPHASE2 · COMPLETED · started Jun 1, 2018ClinicalTrials.gov NCT03405714 · fetched Nov 12, 2026
- Human Epilepsy Project 2: Resistant Focal Seizures StudyCOMPLETED · started May 7, 2018ClinicalTrials.gov NCT03531008 · fetched Nov 12, 2026
- Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant EpilepsyPHASE2 · COMPLETED · started Feb 12, 2018ClinicalTrials.gov NCT03373383 · fetched Nov 12, 2026
- Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseasePHASE3 · COMPLETED · started Nov 3, 2017ClinicalTrials.gov NCT03357471 · fetched Nov 12, 2026
- Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia GravisPHASE2 · COMPLETED · started May 15, 2017ClinicalTrials.gov NCT03052751 · fetched Nov 12, 2026
- Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms ManagementPHASE4 · COMPLETED · started Mar 16, 2017ClinicalTrials.gov NCT03103919 · fetched Nov 12, 2026
- A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit SettingPHASE2 · COMPLETED · started Feb 6, 2017ClinicalTrials.gov NCT03021018 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing SpondylitisPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02963506 · fetched Nov 12, 2026
- A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory ArthritisPHASE2 · COMPLETED · started Oct 1, 2016ClinicalTrials.gov NCT02969525 · fetched Nov 12, 2026
- Study to Evaluate Safety and Efficacy of Different Doses of Bimekizumab in Patients With Chronic Plaque PsoriasisPHASE2 · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02905006 · fetched Nov 12, 2026
- A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus ErythematosusPHASE2 · COMPLETED · started Jun 2, 2016ClinicalTrials.gov NCT02804763 · fetched Nov 12, 2026
- Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)PHASE3 · COMPLETED · started Feb 11, 2015ClinicalTrials.gov NCT02346240 · fetched Nov 12, 2026
- An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)PHASE3 · COMPLETED · started Dec 16, 2014ClinicalTrials.gov NCT02326298 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)PHASE3 · COMPLETED · started Dec 15, 2014ClinicalTrials.gov NCT02326272 · fetched Nov 12, 2026
- A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure ClustersPHASE3 · TERMINATED · started May 1, 2014ClinicalTrials.gov NCT02161185 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMUPHASE3 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01999777 · fetched Nov 12, 2026
- Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure ClustersPHASE3 · TERMINATED · started Jul 1, 2012ClinicalTrials.gov NCT01529034 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure ClustersPHASE3 · TERMINATED · started Jun 1, 2011ClinicalTrials.gov NCT01390220 · fetched Nov 12, 2026